164 related articles for article (PubMed ID: 11245112)
1. Comparison of Tc-99m sestamibi and TI-201 uptake in multiple myeloma.
Chun KA; Cho IH; Won KC; Lee KH; Lee HW; Hyun MS; Hayashida K
Clin Nucl Med; 2001 Mar; 26(3):212-5. PubMed ID: 11245112
[TBL] [Abstract][Full Text] [Related]
2. Technetium-99m 2-methoxy-isobutyl-isonitrile uptake scintigraphy in detection of the bone marrow infiltration in multiple myeloma: correlation with MRI and other prognostic factors.
Erten N; Saka B; Berberoglu K; Turkmen C; Unal S; Bakir B; Yekeler E; Besisik SK
Ann Hematol; 2007 Nov; 86(11):805-13. PubMed ID: 17684742
[TBL] [Abstract][Full Text] [Related]
3. Tc-99m sestamibi scintigraphy in multiple myeloma.
Di Gennaro F; Catalano L; Pace L; de Renzo A; Pinto AM; del Vecchio S; Rotoli B; Salvatore M
Clin Nucl Med; 1999 Feb; 24(2):115-6. PubMed ID: 9988070
[TBL] [Abstract][Full Text] [Related]
4. Different patterns of technetium-99m sestamibi uptake in multiple myeloma.
Pace L; Catalano L; Pinto A; De Renzo A; Di Gennaro F; Califano C; Del Vecchio S; Rotoli B; Salvatore M
Eur J Nucl Med; 1998 Jul; 25(7):714-20. PubMed ID: 9662593
[TBL] [Abstract][Full Text] [Related]
5. Technetium-99m-sestamibi scintigraphy in multiple myeloma and related gammopathies: a useful tool for the identification and follow-up of myeloma bone disease.
Balleari E; Villa G; Garrè S; Ghirlanda P; Agnese G; Carletto M; Clavio M; Ferrando F; Gobbi M; Mariani G; Ghio R
Haematologica; 2001 Jan; 86(1):78-84. PubMed ID: 11146575
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma.
Blocklet D; Schoutens A; Kentos A; Feremans W
Eur J Nucl Med; 2001 Sep; 28(9):1430-2. PubMed ID: 11585304
[No Abstract] [Full Text] [Related]
7. 99mTc-sestamibi imaging and bone marrow karyotyping in the assessment of multiple myeloma and MGUS.
Giovanella L; Taborelli M; Ceriani L; Zucca E; Cavalli F; Delaloye AB
Nucl Med Commun; 2008 Jun; 29(6):535-41. PubMed ID: 18458600
[TBL] [Abstract][Full Text] [Related]
8. Tc-99m methoxyisobutylisonitrile bone marrow imaging for predicting the levels of myeloma cells in bone marrow in multiple myeloma: correlation with CD38/CD138 expressing myeloma cells.
Ak I; Aslan V; Vardareli E; Gülbaş Z
Ann Hematol; 2003 Feb; 82(2):88-92. PubMed ID: 12601486
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
[TBL] [Abstract][Full Text] [Related]
10. Reverse of the differential uptake intensity of Tc-99m MIBI and Tc-99m V-DMSA by multiple myeloma lesions in response to therapy.
Athanasoulis T; Koutsikos J; Moulopoulos LA; Tsiouris S; Dimopoulos MA; Zerva C
Clin Nucl Med; 2003 Aug; 28(8):631-5. PubMed ID: 12897645
[TBL] [Abstract][Full Text] [Related]
11. Tc 99m Sestamibi Scanning in Multiple Myeloma--a New look with SPECT-CT.
Luthra K; Bhave A; Lele RD
J Assoc Physicians India; 2014 Sep; 62(9):801-12. PubMed ID: 26259316
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of F-18 fluorodeoxyglucose bone marrow uptake in patients with recent diagnosis of multiple myeloma: a comparative study with Tc-99m sestamibi.
Castellani M; Carletto M; Baldini L; Calori R; Longari V; Soligo D; Dellavedova L; Gerundini P
Clin Nucl Med; 2010 Jan; 35(1):1-5. PubMed ID: 20026963
[TBL] [Abstract][Full Text] [Related]
13. Hepatic and splenic uptake of Tc-99m HDP in multiple myeloma: additional findings on Tc-99m MIBI and Tc-99m sulfur colloid images.
Berk F; Demir H; Hacihanefioglu A; Arslan A; Erdincler O; Isgoren S; Aktolun C
Ann Nucl Med; 2002 Apr; 16(2):137-41. PubMed ID: 12043908
[TBL] [Abstract][Full Text] [Related]
14. Value of Tc-99m sestamibi scintigraphy in the detection of bone lesions in multiple myeloma: comparison with Tc-99m methylene diphosphonate.
Alexandrakis MG; Kyriakou DS; Passam F; Koukouraki S; Karkavitsas N
Ann Hematol; 2001 Jun; 80(6):349-53. PubMed ID: 11475149
[TBL] [Abstract][Full Text] [Related]
15. Multiple myeloma: predictive value of Tc-99m MIBI scintigraphy and MRI in its diagnosis and therapy.
Myslivecek M; Nekula J; Bacovsky J; Scudla V; Koranda P; Kaminek M
Nucl Med Rev Cent East Eur; 2008; 11(1):12-6. PubMed ID: 19173182
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma.
Fonti R; Del Vecchio S; Zannetti A; De Renzo A; Di Gennaro F; Catalano L; Califano C; Pace L; Rotoli B; Salvatore M
Eur J Nucl Med; 2001 Feb; 28(2):214-20. PubMed ID: 11303893
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of technetium-99m sestamibi in patients with multiple myeloma and potential role in the follow-up.
Pace L; Catalano L; Del Vecchio S; Di Gennaro F; De Renzo A; Sica G; Califano C; Tedesco N; Borrelli G; Rotoli B; Salvatore M
Eur J Nucl Med; 2001 Mar; 28(3):304-12. PubMed ID: 11315597
[TBL] [Abstract][Full Text] [Related]
18. A new semiquantitative method for comparing brain tumor uptake of Tc-99m sestamibi and TI-201.
San Pedro EC; Yilmaz M; Liu HG; Rosenfeld SS; Mountz JM
Clin Nucl Med; 1999 Nov; 24(11):868-73. PubMed ID: 10551470
[TBL] [Abstract][Full Text] [Related]
19. Detection of focal myeloma lesions by technetium-99m-sestaMIBI scintigraphy.
Catalano L; Pace L; Califano C; Pinto AM; De Renzo A; Di Gennaro F; Del Vecchio S; Fonti R; Salvatore M; Rotoli B
Haematologica; 1999 Feb; 84(2):119-24. PubMed ID: 10091409
[TBL] [Abstract][Full Text] [Related]
20. Technetium-99m sestamibi scintigraphy is sensitive and specific for the staging and the follow-up of patients with multiple myeloma: a multicentre study on 397 scans.
Mele A; Offidani M; Visani G; Marconi M; Cambioli F; Nonni M; Catarini M; Brianzoni E; Berbellini A; Ascoli G; Brunori M; Agostini V; Corvatta L; Isidori A; Spinelli A; Gradari M; Leoni P
Br J Haematol; 2007 Mar; 136(5):729-35. PubMed ID: 17233770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
